; or (B) subject to conditions of approval imposed by the Food and Drug Administration pursuant to section 505–1 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355–1 ), which may require the drug to be administered with post-administration monitoring by a health care professional; . 202. Regulations relating to a special registration for telemedicine Not later than 1 year after the date of enactment of this Act, the Attorney General, in consultation with the Secretary of Health and Human Services, shall promulgate the final regulations required under section 311(h)(2) of the Controlled Substances Act ( 21 U.S.C. 831(h)(2) ). 203. Review of at-home drug disposal systems Section 505–1 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355–1 ) is amended by adding at the end the following: (n) At-Home drug disposal standards and systems (1) Establishment of at-home drug disposal standards Not later than one year after the date of enactment of the SUPPORT for Patients and Communities Reauthorization Act of 2023 , the Secretary shall publish guidance to facilitate the use of at-home safe disposal systems for drugs subject to a risk evaluation and mitigation strategy that includes an element described in subsection (e)(4). (2) Guidance The guidance under paragraph (1) shall include— (A) recommended standards for effective at-home disposal systems to meet the public health or non-retrievability standard; (B) recommended information to include as instruction for use to disseminate with at-home disposal systems